| review article | Q7318358 |
| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P6179 | Dimensions Publication ID | 1029284019 |
| P356 | DOI | 10.1186/1746-1596-8-181 |
| P932 | PMC publication ID | 3833630 |
| P698 | PubMed publication ID | 24188373 |
| P5875 | ResearchGate publication ID | 258280173 |
| P2093 | author name string | Shan Li | |
| Jian Wang | |||
| Xue Qin | |||
| Li Xie | |||
| Yu He | |||
| Taijie Li | |||
| Yanqiong Liu | |||
| Weizhong Tang | |||
| P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 |
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis | Q27860511 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer | Q84035867 | ||
| Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer | Q84753222 | ||
| Nuclear S100A4 is a novel prognostic marker in colorectal cancer | Q84761562 | ||
| Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy. | Q50506281 | ||
| Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. | Q51597972 | ||
| Analysis of pathological risk factors for lymph node metastasis in colorectal cancer. | Q51819038 | ||
| A note on graphical presentation of estimated odds ratios from several clinical trials | Q52553734 | ||
| Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma. | Q54309049 | ||
| Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma | Q73620708 | ||
| Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer | Q73750117 | ||
| Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas | Q77553816 | ||
| The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer | Q79353939 | ||
| Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer | Q79357805 | ||
| Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer | Q82606605 | ||
| Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer | Q83155625 | ||
| Statistical aspects of the analysis of data from retrospective studies of disease | Q27860916 | ||
| S100A4, a mediator of metastasis | Q28278577 | ||
| Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 | Q29615661 | ||
| Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates | Q30538531 | ||
| S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma | Q33490165 | ||
| S100A4 and metastasis: a small actor playing many roles | Q33597019 | ||
| Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging | Q33982101 | ||
| Expression of protein S100A4 is a predictor of recurrence in colorectal cancer | Q34073600 | ||
| S100 proteins and their influence on pro-survival pathways in cancer | Q34337425 | ||
| S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer | Q34469540 | ||
| Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. | Q35015799 | ||
| Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients | Q35083652 | ||
| Overexpression of S100A4 is closely associated with progression of colorectal cancer | Q35435739 | ||
| Increased abundance of a normal cell mRNA sequence accompanies the conversion of rat mammary cuboidal epithelial cells to elongated myoepithellal-llke cells in culture | Q35458829 | ||
| Increasing incidence of colorectal cancer in Asia: implications for screening | Q36300753 | ||
| Clinical significance and prognostic value of S100A4 and matrix metalloproteinase-14 in patients with organ-confined bladder cancer | Q36375312 | ||
| New signals from the invasive front | Q36488744 | ||
| A review of the S100 proteins in cancer | Q36848759 | ||
| Clinical, biological, and molecular aspects of metastasis in colorectal cancer. | Q36868773 | ||
| Overexpression of S100A4 is closely associated with the progression and prognosis of gastric cancer in young patients | Q36919384 | ||
| Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients | Q37057045 | ||
| S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? | Q37103177 | ||
| Metastasis-inducing S100A4 protein: implication in non-malignant human pathologies | Q37264795 | ||
| S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence | Q37959812 | ||
| Chemoprevention in colorectal cancer--where we stand and what we have learned from twenty year's experience | Q37963148 | ||
| Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma | Q38352304 | ||
| Overexpression of protein S100A4 is independently associated with overall survival in stage C colonic cancer but only in cytoplasm at the advancing tumour front. | Q38403572 | ||
| Prognostic significance of calcium-binding protein S100A4 in colorectal cancer | Q38454622 | ||
| Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma | Q42279613 | ||
| Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients. | Q46658478 | ||
| Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma | Q47631836 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| S-100 protein | Q596366 | ||
| colorectal carcinoma | Q25493920 | ||
| colorectal neoplasm | Q58833976 | ||
| overexpression | Q61643320 | ||
| tumor biomarker | Q66205818 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 181 | |
| P577 | publication date | 2013-11-04 | |
| P1433 | published in | Diagnostic Pathology | Q18397261 |
| P1476 | title | Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis | |
| P478 | volume | 8 |
| Q41125929 | Deregulated miR-296/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer |
| Q35117340 | Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer |
| Q26768261 | Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis |
| Q33907264 | Lack of association between a functional polymorphism (rs1800796) in the interleukin-6 gene promoter and lung cancer |
| Q33559160 | Meta-analyses between 18 candidate genetic markers and overweight/obesity |
| Q88956893 | Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology |
| Q33688271 | Operative versus conservative treatment for patellar dislocation: a meta-analysis of 7 randomized controlled trials |
| Q35675544 | Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis |
| Q37148928 | Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy |
| Q26765942 | Role of S100 Proteins in Colorectal Carcinogenesis |
| Q64996301 | S100A4 May Be a Good Prognostic Marker and a Therapeutic Target for Colon Cancer. |
| Q57072975 | S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue |
| Q26743403 | S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction |
| Q42700673 | S100A4 in cancer progression and metastasis: A systematic review |
| Q40102636 | Underlying Mechanisms for Distant Metastasis - Molecular Biology |
| Q35191814 | XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis |
Search more.